Amphetamine Sulfate
13 NDCs across 7 manufacturers|12 Generic,1 Brand
Amphetamine Sulfate is used to treat attention deficit disorder with hyperactivity and narcolepsy, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Jan 30, 2019, and the first generic was approved Aug 31, 1984. In 2024, Medicare Part D spent $202K on Amphetamine Sulfate across 1,070 claims for 235 beneficiaries.
Amphetamine Sulfate is available as 13 NDCs from 7 manufacturers (12 generic, 1 brand), with NADAC prices from $0.41 to $7.69 per EA — the most expensive product costs about 19× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
13
12G / 1B
Manufacturers
7
competing in market
Price Spread
$0.41 – $7.69
per EA
7d Activity
avg +6.2% WoW · of 13 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Sun Pharmaceutical Industries Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Central Nervous System Stimulant class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
7 manufacturers producing AMPHETAMINE SULFATE(1 pricing outlier)
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
EVEKEO 10 MG TABLET | $7.6897 per EA | — |
AMPHETAMINE SULFATE 5 MG TAB | $0.6050 per EA | — |
AMPHETAMINE SULFATE 10 MG TAB | $0.5488 per EA | — |
AMPHETAMINE SULFATE 5 MG TAB | $0.4573 per EA | +7.17% |
AMPHETAMINE SULFATE 5 MG TAB | $0.4573 per EA | +7.17% |
AMPHETAMINE SULFATE 5 MG TAB | $0.4573 per EA | +7.17% |
AMPHETAMINE SULFATE 5 MG TAB | $0.4573 per EA | +7.17% |
AMPHETAMINE SULFATE 10 MG TAB | $0.4490 per EA | +5.15% |
AMPHETAMINE SULFATE 10 MG TAB | $0.4490 per EA | +5.15% |
AMPHETAMINE SULFATE 10 MG TAB | $0.4490 per EA | +5.15% |
AMPHETAMINE SULFATE 10 MG TAB | $0.4490 per EA | +5.15% |
AMPHETAMINE SULFATE 5 MG TAB | $0.4247 per EA | — |
AMPHETAMINE SULFATE 10 MG TAB | $0.4091 per EA | — |
Frequently Asked Questions
What is Amphetamine Sulfate used to treat?
Amphetamine Sulfate is used to treat attention deficit disorder with hyperactivity and narcolepsy, per the National Library of Medicine's MED-RT classification.
When did Amphetamine Sulfate become available as a generic?
FDA approved the first generic Amphetamine Sulfate (ANDA) on Aug 31, 1984.
How much does Medicare spend on Amphetamine Sulfate?
In 2024, Medicare Part D spent $202K on Amphetamine Sulfate across 1,070 claims for 235 beneficiaries.
How many Amphetamine Sulfate products are on the market?
The Amphetamine Sulfate drug market contains 13 NDCs from 7 manufacturers — 12 generic and 1 brand product.
What is the price range for Amphetamine Sulfate?
NADAC reference prices for Amphetamine Sulfate range from $0.4091 to $7.6897 per EA — the most expensive product costs about 19× the cheapest.
Is generic Amphetamine Sulfate cheaper than brand?
The average generic NADAC for Amphetamine Sulfate is $0.4677 per EA, versus $7.6897 for brand-labeled products — brand versions average about 16× the generic price.
Which manufacturers make Amphetamine Sulfate?
7 manufacturers list Amphetamine Sulfate in NADAC. Ranked by number of NDCs, the largest are Sun Pharmaceutical Industries Inc. (2), Lannett Company Inc. (2), Granules Pharmaceuticals Inc. (2), Solco Healthcare US LLC (2), Wilshire Pharmaceuticals Inc. (2).
How has the price of Amphetamine Sulfate changed recently?
Over the past 7 days, 8 Amphetamine Sulfate NDCs rose and 0 fell, with a market-wide average change of +6.2%.